pLKO-RB1-shRNA19 Citations (8)

Originally described in: Pharmacologic inhibition of cyclin-dependent kinases 4 and 6 arrests the growth of glioblastoma multiforme intracranial xenografts.
Michaud K, Solomon DA, Oermann E, Kim JS, Zhong WZ, Prados MD, Ozawa T, James CD, Waldman T Cancer Res. 2010 Apr 15. 70(8):3228-38. PubMed Journal

---

Articles Citing pLKO-RB1-shRNA19

Articles
Rb suppresses collective invasion, circulation and metastasis of breast cancer cells in CD44-dependent manner. Kim KJ, Godarova A, Seedle K, Kim MH, Ince TA, Wells SI, Driscoll JJ, Godar S. PLoS One. 2013 Dec 4;8(12):e80590. doi: 10.1371/journal.pone.0080590. eCollection 2013. PubMed
Ras regulates Rb via NORE1A. Barnoud T, Donninger H, Clark GJ. J Biol Chem. 2015 Dec 16. pii: jbc.M115.697557. PubMed
L1 drives IFN in senescent cells and promotes age-associated inflammation. De Cecco M, Ito T, Petrashen AP, Elias AE, Skvir NJ, Criscione SW, Caligiana A, Brocculi G, Adney EM, Boeke JD, Le O, Beausejour C, Ambati J, Ambati K, Simon M, Seluanov A, Gorbunova V, Slagboom PE, Helfand SL, Neretti N, Sedivy JM. Nature. 2019 Feb;566(7742):73-78. doi: 10.1038/s41586-018-0784-9. Epub 2019 Feb 6. PubMed
Targeting glutamine-addiction and overcoming CDK4/6 inhibitor resistance in human esophageal squamous cell carcinoma. Qie S, Yoshida A, Parnham S, Oleinik N, Beeson GC, Beeson CC, Ogretmen B, Bass AJ, Wong KK, Rustgi AK, Diehl JA. Nat Commun. 2019 Mar 21;10(1):1296. doi: 10.1038/s41467-019-09179-w. PubMed
GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer. Wu Q, Ba-Alawi W, Deblois G, Cruickshank J, Duan S, Lima-Fernandes E, Haight J, Tonekaboni SAM, Fortier AM, Kuasne H, McKee TD, Mahmoud H, Kushida M, Cameron S, Dogan-Artun N, Chen W, Nie Y, Zhang LX, Vellanki RN, Zhou S, Prinos P, Wouters BG, Dirks PB, Done SJ, Park M, Cescon DW, Haibe-Kains B, Lupien M, Arrowsmith CH. Nat Commun. 2020 Aug 21;11(1):4205. doi: 10.1038/s41467-020-18020-8. PubMed
Identification of RUNX1T1 as a potential epigenetic modifier in small-cell lung cancer. He T, Wildey G, McColl K, Savadelis A, Spainhower K, McColl C, Kresak A, Tan AC, Yang M, Abbas A, Dowlati A. Mol Oncol. 2021 Jan;15(1):195-209. doi: 10.1002/1878-0261.12829. Epub 2020 Nov 27. PubMed
Combination of Talazoparib and Palbociclib as a Potent Treatment Strategy in Bladder Cancer. Klein FG, Granier C, Zhao Y, Pan Q, Tong Z, Gschwend JE, Holm PS, Nawroth R. J Pers Med. 2021 Apr 24;11(5). pii: jpm11050340. doi: 10.3390/jpm11050340. PubMed
The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer. Singh N, Ramnarine VR, Song JH, Pandey R, Padi SKR, Nouri M, Olive V, Kobelev M, Okumura K, McCarthy D, Hanna MM, Mukherjee P, Sun B, Lee BR, Parker JB, Chakravarti D, Warfel NA, Zhou M, Bearss JJ, Gibb EA, Alshalalfa M, Karnes RJ, Small EJ, Aggarwal R, Feng F, Wang Y, Buttyan R, Zoubeidi A, Rubin M, Gleave M, Slack FJ, Davicioni E, Beltran H, Collins C, Kraft AS. Nat Commun. 2021 Dec 21;12(1):7349. doi: 10.1038/s41467-021-26901-9. PubMed

If you have published an article using this material, please email us at to have your article added to this page.